Skip to main content
Print Save

M T12 (Topiramate 50 mg)

Pill with imprint M T12 is White, Round and has been identified as Topiramate 50 mg. It is supplied by Mylan Pharmaceuticals Inc..

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M T12

Topiramate 50 mg M T12
Topiramate 50 mg M T12

Save up to 80% off prescription medications

Click here for your free Discount Card

Topiramate

Imprint
M T12
Strength
50 mg
Color
White
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, silicon dioxide, hypromelloses, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, povidone, sodium lauryl sulfate, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-6102 (Discontinued) Mylan Pharmaceuticals Inc.
51079-0727 (Discontinued) UDL Laboratories Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related Images for "M T12"

Ultrase MT 12 39,000 units amylase; 12,000 units lipase; 39,000 units protease ULTRASE MT 12
Ultrase MT 12
Promethazine Hydrochloride 12.5 mg M PT 12
Promethazine Hydrochloride
Dimethyl Fumarate Delayed-Release 120 mg T127 120 mg
Dimethyl Fumarate Delayed-Release

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer